Capital Financial Services’s Pfizer PFE Stock Holding History

Capital Financial Services’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$3.67M	Sell	71,624 -3,075	-4%	-$147K	5.06%	4
2022 Q3	$3.27M	Sell	74,699 -400	-0.5%	-$19.4K	4.83%	4
2022 Q2	$3.94M	Buy	75,099 +150	+0.2%	+$7.64K	5.55%	3
2022 Q1	$3.88M	Buy	74,949 +180	+0.2%	+$9.34K	4.56%	4
2021 Q4	$4.42M	Sell	74,769 -1,130	-1%	-$56K	4.82%	3
2021 Q3	$3.26M	Buy	75,899 +150	+0.2%	+$6.64K	3.99%	4
2021 Q2	$2.97M	Sell	75,749 -950	-1%	-$36.9K	3.77%	6
2021 Q1	$2.78M	Hold	76,699	–	–	3.71%	6
2020 Q4	$2.82M	Buy	+76,699	New	+$2.81M	3.93%	5

Other funds holding PFE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital Financial Services's PFE Position: Q4 2022 in Review

Capital Financial Services reduced its Pfizer (PFE) stake by 4.1% in Q4 2022, selling an estimated $147K and leaving 71,624 shares worth $3.67M. The position accounts for 5.06% of the portfolio, ranked #4.

Capital Financial Services first reported a position in PFE in Q4 2020 and has held it in 9 quarters since. The position peaked at $4.42M in Q4 2021. 3,265 funds tracked by Wall St. Rank hold PFE as of Q4 2022.

Capital Financial Services held 71,624 shares of Pfizer worth $3.67M as of Q4 2022.
Capital Financial Services sold 3,075 Pfizer shares in Q4 2022, an estimated $147K.
Pfizer made up 5.06% of Capital Financial Services's portfolio in Q4 2022, its #4 holding.
Capital Financial Services first reported a position in Pfizer in Q4 2020 and has held it in 9 quarters since.
Capital Financial Services's Pfizer position peaked at $4.42M in Q4 2021.
3,265 funds tracked by Wall St. Rank held Pfizer as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.